Case Report
PDF Zotero Mendeley EndNote BibTex Cite

Rare nervous system involvement in an anti-myelin oligodendrocyte-positive case: spinal leptomeningeal involvement

Year 2022, Volume 6, Issue 4, 540 - 542, 01.04.2022
https://doi.org/10.28982/josam.955602

Abstract

Anti-myelin oligodendrocyte (MOG)-positive cases have a variable clinical presentation. MOG autoantibodies are associated with acute disseminated encephalomyelitis, multiple sclerosis, clinically isolated syndrome, neuromyelitis optica, isolated optic neuritis, and transverse myelitis. Our patient had bilateral optic neuritis with acute tetraparesis. Cranial magnetic resonance imaging (MRI) showed leptomeningeal contrast involvement and contrast enhancement in all cranial nerve nuclei. Spinal MRI revealed leptomeningeal contrast enhancement, and a contrast-enhancing lesion was found in the cervical spinal cord. This case is worth presenting because spinal leptomeningeal involvement is rare in anti-MOG-positive patients.

References

  • 1. Brunner C, Lassmann H, Waehneldt TV, Matthieu JM, Linington C. Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats. J Neurochem. 1989 Jan;52(1):296-304. doi: 10.1111/j.1471-4159.1989.tb10930.x. PMID: 2462020.
  • 2. Reindl M, Di Pauli F, Rostásy K, Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol. 2013 Aug;9(8):455-61. doi: 10.1038/nrneurol.2013.118. Epub 2013 Jun 25. PMID: 23797245.
  • 3. Tsuburaya RS, Miki N, Tanaka K, Kageyama T, Irahara K, Mukaida S, et al. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis. Brain Dev. 2015 Jan;37(1):145-8. doi: 10.1016/j.braindev.2014.02.002. Epub 2014 Feb 28. PMID: 24582475.
  • 4. Kitley J, Woodhall M, Waters P, Leite MI, Devenney E, Craig J, et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology. 2012 Sep 18;79(12):1273-7. doi: 10.1212/WNL.0b013e31826aac4e. Epub 2012 Aug 22. PMID: 22914827.
  • 5. Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation. 2011 Dec 28;8:184. doi: 10.1186/1742-2094-8-184. PMID: 22204662; PMCID: PMC3278385.
  • 6. Rostásy K, Mader S, Hennes EM, Schanda K, Gredler V, Guenther A, et al. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler. 2013 Jul;19(8):1052-9. doi: 10.1177/1352458512470310. Epub 2012 Dec 20. PMID: 23257621.
  • 7. Huppke P, Rostasy K, Karenfort M, Huppke B, Seidl R, Leiz S, et al. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler. 2013 Jun;19(7):941-6. doi: 10.1177/1352458512466317. Epub 2012 Nov 5. PMID: 23128668.
  • 8. Dos Passos GR, Oliveira LM, da Costa BK, Apostolos-Pereira SL, Callegaro D, Fujihara K, et al. MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder. Front Neurol. 2018 Apr 4;9:217. doi: 10.3389/fneur.2018.00217. PMID: 29670575; PMCID: PMC5893792.
  • 9. Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, et al; in cooperation with the Neuromyelitis Optica Study Group (NEMOS). MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome. J Neuroinflammation. 2016 Nov 1;13(1):281. doi: 10.1186/s12974-016-0719-z. PMID: 27802825; PMCID: PMC5088671.
  • 10. Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017 Dec 1;140(12):3128-38. doi: 10.1093/brain/awx276. Erratum in: Brain. 2018 Apr 1;141(4):e31. PMID: 29136091.
  • 11. Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC, et al; Australasian and New Zealand MOG Study Group. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):127-37. doi: 10.1136/jnnp-2017-316880. Epub 2017 Nov 15. PMID: 29142145; PMCID: PMC5800335.
  • 12. Mohseni SH, Skejoe HPB, Wuerfel J, Paul F, Reindl M, Jarius S, et al. Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG-Positive Patient. Case Rep Neurol Med. 2018 Dec 9;2018:1365175. doi: 10.1155/2018/1365175. PMID: 30834146; PMCID: PMC6374805.
  • 13. Haddad N, Roussel B, Pelcovits A, Rizvi S. Optic neuritis, encephalitis and leptomeningeal enhancement in a patient with anti-MOG antibodies: A case study. Mult Scler Relat Disord. 2019 Sep;34:14-16. doi: 10.1016/j.msard.2019.06.010. Epub 2019 Jun 14. PMID: 31226544.
  • 14. Fujimori J, Nakamura M, Yagihashi T, Nakashima I. Clinical and Radiological Features of Adult Onset Bilateral Medial Frontal Cerebral Cortical Encephalitis With Anti-myelin Oligodendrocyte Glycoprotein Antibody. Front Neurol. 2020 Dec 16;11:600169. doi: 10.3389/fneur.2020.600169. PMID: 33391163; PMCID: PMC7772389.
  • 15. Shen W, Zhang Y, Zhou C, Shen Y. Bilateral symmetrical deep gray matter involvement and leptomeningeal enhancement in a child with MOG-IgG-associated encephalomyelitis. BMC Neurol. 2021 Jan 8;21(1):10. doi: 10.1186/s12883-020-02041-3. PMID: 33419414; PMCID: PMC7791788.
  • 16. Nakamura M, Iwasaki Y, Takahashi T, Kaneko K, Nakashima I, Kunieda T, et al. A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection. Mult Scler Relat Disord. 2017 Oct;17:148-150. doi: 10.1016/j.msard.2017.07.023. Epub 2017 Jul 27. PMID: 29055448.
  • 17. Høglund RA, Myro AZ, Zarnovicky S, Holmøy T. A young woman with seizures, visual impairment, and paralysis. Tidsskr Nor Laegeforen. 2019 Aug 19;139(11). Norwegian, English. doi: 10.4045/tidsskr.19.0122. PMID: 31429234.
  • 18. Denève M, Biotti D, Patsoura S, Ferrier M, Meluchova Z, Mahieu L, et al. MRI features of demyelinating disease associated with anti-MOG antibodies in adults. J Neuroradiol. 2019 Sep;46(5):312-8. doi: 10.1016/j.neurad.2019.06.001. Epub 2019 Jun 20. PMID: 31228536.

Year 2022, Volume 6, Issue 4, 540 - 542, 01.04.2022
https://doi.org/10.28982/josam.955602

Abstract

References

  • 1. Brunner C, Lassmann H, Waehneldt TV, Matthieu JM, Linington C. Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats. J Neurochem. 1989 Jan;52(1):296-304. doi: 10.1111/j.1471-4159.1989.tb10930.x. PMID: 2462020.
  • 2. Reindl M, Di Pauli F, Rostásy K, Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol. 2013 Aug;9(8):455-61. doi: 10.1038/nrneurol.2013.118. Epub 2013 Jun 25. PMID: 23797245.
  • 3. Tsuburaya RS, Miki N, Tanaka K, Kageyama T, Irahara K, Mukaida S, et al. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis. Brain Dev. 2015 Jan;37(1):145-8. doi: 10.1016/j.braindev.2014.02.002. Epub 2014 Feb 28. PMID: 24582475.
  • 4. Kitley J, Woodhall M, Waters P, Leite MI, Devenney E, Craig J, et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology. 2012 Sep 18;79(12):1273-7. doi: 10.1212/WNL.0b013e31826aac4e. Epub 2012 Aug 22. PMID: 22914827.
  • 5. Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation. 2011 Dec 28;8:184. doi: 10.1186/1742-2094-8-184. PMID: 22204662; PMCID: PMC3278385.
  • 6. Rostásy K, Mader S, Hennes EM, Schanda K, Gredler V, Guenther A, et al. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler. 2013 Jul;19(8):1052-9. doi: 10.1177/1352458512470310. Epub 2012 Dec 20. PMID: 23257621.
  • 7. Huppke P, Rostasy K, Karenfort M, Huppke B, Seidl R, Leiz S, et al. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler. 2013 Jun;19(7):941-6. doi: 10.1177/1352458512466317. Epub 2012 Nov 5. PMID: 23128668.
  • 8. Dos Passos GR, Oliveira LM, da Costa BK, Apostolos-Pereira SL, Callegaro D, Fujihara K, et al. MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder. Front Neurol. 2018 Apr 4;9:217. doi: 10.3389/fneur.2018.00217. PMID: 29670575; PMCID: PMC5893792.
  • 9. Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, et al; in cooperation with the Neuromyelitis Optica Study Group (NEMOS). MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome. J Neuroinflammation. 2016 Nov 1;13(1):281. doi: 10.1186/s12974-016-0719-z. PMID: 27802825; PMCID: PMC5088671.
  • 10. Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017 Dec 1;140(12):3128-38. doi: 10.1093/brain/awx276. Erratum in: Brain. 2018 Apr 1;141(4):e31. PMID: 29136091.
  • 11. Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC, et al; Australasian and New Zealand MOG Study Group. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):127-37. doi: 10.1136/jnnp-2017-316880. Epub 2017 Nov 15. PMID: 29142145; PMCID: PMC5800335.
  • 12. Mohseni SH, Skejoe HPB, Wuerfel J, Paul F, Reindl M, Jarius S, et al. Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG-Positive Patient. Case Rep Neurol Med. 2018 Dec 9;2018:1365175. doi: 10.1155/2018/1365175. PMID: 30834146; PMCID: PMC6374805.
  • 13. Haddad N, Roussel B, Pelcovits A, Rizvi S. Optic neuritis, encephalitis and leptomeningeal enhancement in a patient with anti-MOG antibodies: A case study. Mult Scler Relat Disord. 2019 Sep;34:14-16. doi: 10.1016/j.msard.2019.06.010. Epub 2019 Jun 14. PMID: 31226544.
  • 14. Fujimori J, Nakamura M, Yagihashi T, Nakashima I. Clinical and Radiological Features of Adult Onset Bilateral Medial Frontal Cerebral Cortical Encephalitis With Anti-myelin Oligodendrocyte Glycoprotein Antibody. Front Neurol. 2020 Dec 16;11:600169. doi: 10.3389/fneur.2020.600169. PMID: 33391163; PMCID: PMC7772389.
  • 15. Shen W, Zhang Y, Zhou C, Shen Y. Bilateral symmetrical deep gray matter involvement and leptomeningeal enhancement in a child with MOG-IgG-associated encephalomyelitis. BMC Neurol. 2021 Jan 8;21(1):10. doi: 10.1186/s12883-020-02041-3. PMID: 33419414; PMCID: PMC7791788.
  • 16. Nakamura M, Iwasaki Y, Takahashi T, Kaneko K, Nakashima I, Kunieda T, et al. A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection. Mult Scler Relat Disord. 2017 Oct;17:148-150. doi: 10.1016/j.msard.2017.07.023. Epub 2017 Jul 27. PMID: 29055448.
  • 17. Høglund RA, Myro AZ, Zarnovicky S, Holmøy T. A young woman with seizures, visual impairment, and paralysis. Tidsskr Nor Laegeforen. 2019 Aug 19;139(11). Norwegian, English. doi: 10.4045/tidsskr.19.0122. PMID: 31429234.
  • 18. Denève M, Biotti D, Patsoura S, Ferrier M, Meluchova Z, Mahieu L, et al. MRI features of demyelinating disease associated with anti-MOG antibodies in adults. J Neuroradiol. 2019 Sep;46(5):312-8. doi: 10.1016/j.neurad.2019.06.001. Epub 2019 Jun 20. PMID: 31228536.

Details

Primary Language English
Subjects Clinical Neurology
Journal Section Case report
Authors

Buket TUĞAN YILDIZ (Primary Author)
Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi
0000-0001-6783-2336
Türkiye


Deniz TUNCEL
KAHRAMANMARAŞ SÜTÇÜ İMAM ÜNİVERSİTESİ, TIP FAKÜLTESİ
0000-0003-2347-472X
Türkiye


Nursel YURTTUTAN
KAHRAMANMARAŞ SÜTÇÜ İMAM ÜNİVERSİTESİ, TIP FAKÜLTESİ
0000-0002-3685-6025
Türkiye


Şerife ÇÖKLÜ This is me
KAHRAMANMARAŞ SÜTÇÜ İMAM ÜNİVERSİTESİ, TIP FAKÜLTESİ
0000-0001-6490-0727
Türkiye

Publication Date April 1, 2022
Published in Issue Year 2022, Volume 6, Issue 4

Cite

Bibtex @case report { josam955602, journal = {Journal of Surgery and Medicine}, issn = {}, eissn = {2602-2079}, address = {jsurgmed@gmail.com}, publisher = {Fatih BAŞAK}, year = {2022}, volume = {6}, pages = {540 - 542}, doi = {10.28982/josam.955602}, title = {Rare nervous system involvement in an anti-myelin oligodendrocyte-positive case: spinal leptomeningeal involvement}, key = {cite}, author = {Tuğan Yıldız, Buket and Tuncel, Deniz and Yurttutan, Nursel and Çöklü, Şerife} }
APA Tuğan Yıldız, B. , Tuncel, D. , Yurttutan, N. & Çöklü, Ş. (2022). Rare nervous system involvement in an anti-myelin oligodendrocyte-positive case: spinal leptomeningeal involvement . Journal of Surgery and Medicine , 6 (4) , 540-542 . DOI: 10.28982/josam.955602
MLA Tuğan Yıldız, B. , Tuncel, D. , Yurttutan, N. , Çöklü, Ş. "Rare nervous system involvement in an anti-myelin oligodendrocyte-positive case: spinal leptomeningeal involvement" . Journal of Surgery and Medicine 6 (2022 ): 540-542 <https://jsurgmed.com/en/pub/issue/69115/955602>
Chicago Tuğan Yıldız, B. , Tuncel, D. , Yurttutan, N. , Çöklü, Ş. "Rare nervous system involvement in an anti-myelin oligodendrocyte-positive case: spinal leptomeningeal involvement". Journal of Surgery and Medicine 6 (2022 ): 540-542
RIS TY - JOUR T1 - Rare nervous system involvement in an anti-myelin oligodendrocyte-positive case: spinal leptomeningeal involvement AU - Buket Tuğan Yıldız , Deniz Tuncel , Nursel Yurttutan , Şerife Çöklü Y1 - 2022 PY - 2022 N1 - doi: 10.28982/josam.955602 DO - 10.28982/josam.955602 T2 - Journal of Surgery and Medicine JF - Journal JO - JOR SP - 540 EP - 542 VL - 6 IS - 4 SN - -2602-2079 M3 - doi: 10.28982/josam.955602 UR - https://doi.org/10.28982/josam.955602 Y2 - 2022 ER -
EndNote %0 Journal of Surgery and Medicine Rare nervous system involvement in an anti-myelin oligodendrocyte-positive case: spinal leptomeningeal involvement %A Buket Tuğan Yıldız , Deniz Tuncel , Nursel Yurttutan , Şerife Çöklü %T Rare nervous system involvement in an anti-myelin oligodendrocyte-positive case: spinal leptomeningeal involvement %D 2022 %J Journal of Surgery and Medicine %P -2602-2079 %V 6 %N 4 %R doi: 10.28982/josam.955602 %U 10.28982/josam.955602
ISNAD Tuğan Yıldız, Buket , Tuncel, Deniz , Yurttutan, Nursel , Çöklü, Şerife . "Rare nervous system involvement in an anti-myelin oligodendrocyte-positive case: spinal leptomeningeal involvement". Journal of Surgery and Medicine 6 / 4 (April 2022): 540-542 . https://doi.org/10.28982/josam.955602
AMA Tuğan Yıldız B. , Tuncel D. , Yurttutan N. , Çöklü Ş. Rare nervous system involvement in an anti-myelin oligodendrocyte-positive case: spinal leptomeningeal involvement. J Surg Med. 2022; 6(4): 540-542.
Vancouver Tuğan Yıldız B. , Tuncel D. , Yurttutan N. , Çöklü Ş. Rare nervous system involvement in an anti-myelin oligodendrocyte-positive case: spinal leptomeningeal involvement. Journal of Surgery and Medicine. 2022; 6(4): 540-542.
IEEE B. Tuğan Yıldız , D. Tuncel , N. Yurttutan and Ş. Çöklü , "Rare nervous system involvement in an anti-myelin oligodendrocyte-positive case: spinal leptomeningeal involvement", Journal of Surgery and Medicine, vol. 6, no. 4, pp. 540-542, Apr. 2022, doi:10.28982/josam.955602

The DNS issue is resolved. jsurgmed.com and current publication are fully accessible.

To use the submission system properly, please use one of the following browsers, Chrome or Firefox, with the latest updates.
If you experience problems, it may be necessary to clear the browser cache and history; and disable blocker extensions, i.e., uBlock, of the browsers
Mobile phones are not recommended, please use a personal computer.